Objective: This study examined acute findings and long-term outcome trajectories between birth and adolescence in children with prenatal opiate exposure.
Study Design: Ninety children (45 opiate-exposed, 45 non-exposed) completed assessments between 1 month and 15 years of age. Outcome variables (medical, anthropomorphic, developmental, and behavioral) were analyzed at individual time points and using longitudinal statistical modeling.
Results: Opiate-exposed infants displayed transient neurologic findings, but no substantial signs or symptoms long term. There were no group differences in growth, cognitive functioning, or behavior at individual time periods; however, the trajectories of outcomes using longitudinal analyses adjusting for variables known to impact outcome demonstrated increased deficits among opiate-exposed children over time with regards to weight, head circumference, cognitive functioning, and behavior.
Conclusions: Findings support concerns that maternal opiate use during pregnancy may negatively impact a child's developmental trajectory, which in turn may impose concerns to society (e.g., increased need for social, medical, and/or educational services).
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41372-020-0692-3 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Differential Effects of Prenatal Buprenorphine and Methadone on Postnatal Growth and Gene Expression in the Nucleus Accumbens.
Dev Psychobiol
January 2025
Department of Comparative Pathobiology, Cummings School of Veterinary Medicine, Tufts University, North Grafton, Massachusetts, USA.
Methadone and buprenorphine are commonly prescribed during pregnancy to maintain recovery and prevent symptoms of withdrawal in women with opioid use disorder. Infants prenatally exposed to medications for opioid use disorder (MOUD), however, commonly show signs of neonatal opioid withdrawal syndrome (NOWS), which can include feeding-related issues like hyperphagia. To investigate the effects of prenatal MOUD exposure on feeding behavior, female Sprague-Dawley rats were implanted with osmotic minipumps filled with methadone, buprenorphine, or saline and subsequently mated.
View Article and Find Full Text PDFBrain region-specific neural activation by low-dose opioid promotes social behavior.
JCI Insight
December 2024
Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences, and.
The opioid system plays crucial roles in modulating social behaviors in both humans and animals. However, the pharmacological profiles of opioids regarding social behavior and their therapeutic potential remain unclear. Multiple pharmacological, behavioral, and immunohistological c-Fos mapping approaches were used to characterize the effects of μ-opioid receptor agonists on social behavior and investigate the mechanisms in naive mice and autism spectrum disorder-like (ASD-like) mouse models, such as prenatally valproic acid-treated mice and Fmr1-KO mice.
View Article and Find Full Text PDFAccidental Detection of Cocaine in Urine in Pediatric Patients: Case Series and Literature Review.
Children (Basel)
October 2024
Responsible GAIA Service, Meyer Children's Hospital IRCCS, Viale Pieraccini 24, 50139 Florence, Italy.
Infantile occult exposure to cocaine in domestic environments represents a complex clinical and medico-legal problem, which can be associated with abuse and neglect and with potential short- and long-term health risks for children. The authors present a retrospective study on 764 children under 14 years old who accessed the Emergency Department of IRCCS Meyer from 2016 to 2023 and were included in the GAIA (Child and Adolescent Abuse Group) protocol for suspected maltreatment and abuse, and for which a urine toxicology analysis was performed. The aim is to discuss the medico-legal implications and highlight the need for a thorough evaluation and management of such situations.
View Article and Find Full Text PDFPrenatal buprenorphine/naloxone exposure and neonatal neurobehavioral functioning: A preliminary report.
Neurotoxicol Teratol
December 2024
Johns Hopkins University School of Medicine, Department of Pediatrics, USA.
Article Synopsis
- - The study examines the neurobehavioral functioning of neonates exposed to buprenorphine/naloxone during pregnancy, addressing the lack of research on the effects of this medication combination on infants.
- - Data was collected from mothers undergoing treatment for opioid use disorder, with the neonates assessed at three different points in their first month of life using the NICU Network Neurobehavioral Scale (NNNS).
- - Results highlighted various neurobehavioral domains affected in these infants and identified maternal factors, such as high rates of smoking and psychiatric disorders, that may impact neonatal development.
Neurodevelopmental outcomes in children prenatally exposed to opioid maintenance treatment: A population-based study.
Pharmacotherapy
October 2024
Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, Rhode Island, USA.
Article Synopsis
- The study investigates the long-term effects of opioid maintenance treatment (OMT) during pregnancy, specifically focusing on the impact of methadone and buprenorphine on childhood neurodevelopmental disorders (NDDs).
- Using Rhode Island Medicaid data from 2008-2018, the research looks at pregnancies with opioid use disorder (OUD) and evaluates the timing of drug exposure during gestation.
- Results indicated that children exposed to methadone in early pregnancy had a significantly higher incidence of NDDs (36%) compared to those exposed to buprenorphine (17%), highlighting a potential risk associated with the timing and type of OMT used.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!